SVFCX
Price
$76.95
Change
-$1.53 (-1.95%)
Updated
Feb 21 closing price
Net Assets
5.83B
VIVAX
Price
$68.80
Change
-$0.81 (-1.16%)
Updated
Feb 21 closing price
Net Assets
192.55B
Ad is loading...

SVFCX vs VIVAX

Header iconSVFCX vs VIVAX Comparison
Open Charts SVFCX vs VIVAXBanner chart's image
Smead Value C
Price$76.95
Change-$1.53 (-1.95%)
VolumeN/A
Net Assets5.83B
Vanguard Value Index I
Price$68.80
Change-$0.81 (-1.16%)
VolumeN/A
Net Assets192.55B
SVFCX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SVFCX vs. VIVAX commentary
Feb 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SVFCX is a Hold and VIVAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 193B vs. SVFCX (5.83B). VIVAX pays higher dividends than SVFCX: VIVAX (2.25) vs SVFCX (0.80). SVFCX was incepted earlier than VIVAX: SVFCX (5 years) vs VIVAX (32 years). SVFCX is a more actively managed with annual turnover of: 15.60 vs. VIVAX (10.00). VIVAX has a lower initial minimum investment than SVFCX: VIVAX (3000) vs SVFCX (25000). VIVAX annual gain was more profitable for investors over the last year : 16.22 vs. SVFCX (4.64).
SVFCXVIVAXSVFCX / VIVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years32 years-
Gain YTD2.8015.82848%
Front LoadN/AN/A-
Min. Initial Investment250003000833%
Min. Initial Investment IRAN/AN/A-
Net Assets5.83B193B3%
Annual Yield % from dividends0.802.2536%
Returns for 1 year4.6416.2229%
Returns for 3 years21.0525.0484%
Returns for 5 yearsN/A49.60-
Returns for 10 yearsN/A109.81-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YQ1.990.04
+2.05%
17 Education & Technology Group
NJR46.450.04
+0.09%
New Jersey Resources Corp
AEM98.04-0.01
-0.01%
Agnico Eagle Mines Ltd
ACIU2.66-0.03
-1.12%
AC Immune SA
OCUL7.25-0.13
-1.76%
Ocular Therapeutix